Janelle R. Anderson, PhD, Managing Partner of CTI Life Sciences Fund, has started a new podcast, Human Proof of Concept, in which she interviews business leaders within the life sciences and venture capital spaces. The goal is to bring light to new medicine and technology.
In the first two episodes, She speaks with Ron Cohen, CEO and founder of Acorda Therapeutics and Chair of BIO. In the interviews, he discusses his career and its challenges/successes, comments on the high drama from 2015 and how it has affected the industry and also discusses the drug pricing conversation that has been especially prevalent lately. He also touches on new trends for biotech coming up.
The Impact Brands: Empowering Wellness Through Natural and Holistic Solutions
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Other podcasts or publications on a similar subject include Lisa Suennen’s Tech Tonics as well as Bruce Booth’s Blog Life Sci VC.
You can listen to the first two episodes of Human Proof of Concept below – both are about thirty minutes long.
Part 1:
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Part 2:
